Trademark: REVNEUZE 2091669
Word
REVNEUZE
ID
2091669
Trademark Type
Word
Status
Cancelled: Cancelled at the request of IB
Application Date
29 January 2020
Registration Date
29 January 2020
Cancellation Date
16 May 2023
Owner(s)
Service
Goods and Services:
Class 5:
Pharmaceutical preparations, namely, medications for the treatment of ischemic stroke, hemorrhagic stroke, transient ischemic attack, Alzheimer's disease, Parkinson's disease, mixed dementia, frontotemporal dementia, dementia with Lewy bodies, vascular dementia, Wernicke-Korsakoff syndrome, Huntington's disease, Creutzfeldt Jakob disease, normal pressure hydrocephalus, spinal cord injury, traumatic brain injury, amyotrophic lateral sclerosis, multiple sclerosis, hypoxic-ischemic injury to the brain or spinal cord and neurodegenerative diseases.
Pharmaceutical preparations, namely, medications for the treatment of ischemic stroke, hemorrhagic stroke, transient ischemic attack, Alzheimer's disease, Parkinson's disease, mixed dementia, frontotemporal dementia, dementia with Lewy bodies, vascular dementia, Wernicke-Korsakoff syndrome, Huntington's disease, Creutzfeldt Jakob disease, normal pressure hydrocephalus, spinal cord injury, traumatic brain injury, amyotrophic lateral sclerosis, multiple sclerosis, hypoxic-ischemic injury to the brain or spinal cord and neurodegenerative diseases.